For Healthcare Professionals Only. Our kits are not sold individually.
IDYLLATM THYROIDPRINT® ASSAY
It is the first cartridge-based test to evaluate a gene expression profile from a fresh FNA sample collected from the nodule for risk stratification of indeterminate thyroid nodules.
IDYLLATM THYROIDPRINT® ASSAY It is the first cartridge-based test based on RT-qPCR that evaluates a gene expression profile from a fresh FNA sample collected from the nodule for risk stratification of indeterminate thyroid nodules. Thyroidprint qPCR data are analyzed with a proprietary algorithm that reports a classifier result based on the expression levels of a combination of 10 epithelial and stromal cell target genes relative to 2 reference genes.
Fully Automatic Sample-to-Result Reporting on the Idylla™ Platform
The Idylla™ ThyroidPrint® Assay covers the entire process from sample to results, including fully integrated sample preparation, nucleic acid extraction, reverse transcription of RNA, real-time PCR amplification and detection, and data analysis and result reporting as appropriate. A report will be generated as a result of ‘HIGH’ or ‘LOW’.
A ‘HIGH’ result is indicative of atypical gene expression. A ‘LOW’ result is indicative of normal gene expression.
A RAPID TEST – PERFORMED IN YOUR LAB IN 160 MINUTES.